Shares of Renalytix Plc (LON:RENX – Get Free Report) traded down 2.8% during mid-day trading on Wednesday . The company traded as low as GBX 8.50 ($0.11) and last traded at GBX 8.75 ($0.11). 323,879 shares traded hands during trading, an increase of 23% from the average session volume of 263,172 shares. The stock had previously closed at GBX 9 ($0.12).
Renalytix Stock Down 2.8 %
The firm has a market capitalization of £36.27 million, a P/E ratio of -0.41 and a beta of 2.10. The business has a 50 day moving average price of GBX 10.28 and a 200 day moving average price of GBX 9.36. The company has a debt-to-equity ratio of -72.91, a current ratio of 0.24 and a quick ratio of 2.42.
About Renalytix
Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S.
Read More
- Five stocks we like better than Renalytix
- What is a Special Dividend?
- Energy Transfer: Powering Data With Dividends and Diversification
- The Significance of Brokerage Rankings in Stock Selection
- Qualcomm Stock Is Coiling for a Breakout
- What Do S&P 500 Stocks Tell Investors About the Market?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
